Skip to
  1. Homepage
  2. Rare diseases
  3. Search
Simple search

Simple search

*
(*) mandatory field





 

Other search option(s)

Hepatoblastoma

Orpha number ORPHA449
Synonym(s) -
Prevalence Unknown
Inheritance
  • Sporadic
Age of onset Childhood
ICD-10
  • C22.2
OMIM -
UMLS
  • C0206624
MeSH
  • D018197
MedDRA
  • 10062001
SNOMED CT
  • 109843000
  • 45024009

Summary

Hepatoblastoma (HB) is a rare tumour but represents the commonest primary malignant tumour of the liver in childhood. It accounts for about 1% of all childhood tumours with an annual incidence of 1.5 cases per million children younger than 15 years. The onset of HB occurs at a median age of 18-24 months. Serum alpha-fetoprotein levels are frequently elevated. Main symptoms are palpable hepatic mass and abdominal pain. Systemic symptoms are rare. HB might be associated with Beckwith-Wiedemann syndrome and familial adenomatous polyposis. Treatment of HB combines cisplatin-based chemotherapy and surgery. In Europe, HB is typically treated with preoperative chemotherapy, followed by tumour resection and a short course of postoperative chemotherapy, whereas primary surgery followed by adjuvant chemotherapy is the recommended treatment strategy in the United States.

Expert reviewer(s)

  • Dr P CZAUDERNA
  • Pr Giorgio PERILONGO

(*) Required fields.

Attention: Only comments seeking to improve the quality and accuracy of information on the Orphanet website are accepted. For all other comments, please send your remarks via contact us. Only comments written in English can be processed.


Captcha image

Detailed information

Clinical practice guidelines
  • DE (2010)
Get Acrobat Reader
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.